PTC THERAPEUTICS

Summary

PTC Therapeutics provides biopharmaceutical products. The Company develops orally administered and small-molecule drugs for genetic disorders, oncology, and infectious diseases. PTC Therapeutics operates in the United States.

Deals Overview

Total Deals21

Valued Deals14

Total Value£ 34.44 B

Avg. Deal Size£ 2.46 B

Market Context

Subsidiaries

ROCHE HOLDINGS AG

20 transactions

Senior Management

Stuart W. Peltz
CEO
Stuart W. Peltz
CEO